BioTech/Drugs - Laval, Quebec, CA
Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissue implants that target liver failure. The Company is supported by Series A investment to achieve Phase 1 clinical trials. Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure.
Outlook
Varnish
Google Tag Manager
Facebook Login (Connect)
Google Cloud Hosting
Mobile Friendly